Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127740131 | 12774013 | 1 | I | 20140607 | 20160915 | 20160923 | 20160923 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-077416 | BRISTOL MYERS SQUIBB | 55.98 | YR | F | Y | 0.00000 | 20160923 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127740131 | 12774013 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 5 MG, QD | Y | 21436 | 5 | MG | TABLET | QD | |||||
| 127740131 | 12774013 | 2 | SS | DEROXAT | PAROXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, QD | U | 0 | 60 | MG | QD | ||||||
| 127740131 | 12774013 | 3 | SS | DEROXAT | PAROXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, UNK | U | 0 | 20 | MG | QD | ||||||
| 127740131 | 12774013 | 4 | SS | NOZINAN /00038601/ | LEVOMEPROMAZINE | 1 | Oral | 25 MG, TID | Y | 0 | 25 | MG | TID | ||||||
| 127740131 | 12774013 | 5 | C | NOVOMIX | INSULIN ASPART | 1 | Unknown | U | 0 | ||||||||||
| 127740131 | 12774013 | 6 | C | LYSANXIA | PRAZEPAM | 1 | Unknown | U | 0 | ||||||||||
| 127740131 | 12774013 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 127740131 | 12774013 | 8 | C | VICTOZA | LIRAGLUTIDE | 1 | Unknown | U | 0 | ||||||||||
| 127740131 | 12774013 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127740131 | 12774013 | 10 | C | NOVORAPID | INSULIN ASPART | 1 | Unknown | U | 0 | ||||||||||
| 127740131 | 12774013 | 11 | C | NOCTAMIDE | LORMETAZEPAM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127740131 | 12774013 | 1 | Depression |
| 127740131 | 12774013 | 2 | Depression |
| 127740131 | 12774013 | 4 | Depression |
| 127740131 | 12774013 | 5 | Product used for unknown indication |
| 127740131 | 12774013 | 6 | Product used for unknown indication |
| 127740131 | 12774013 | 7 | Product used for unknown indication |
| 127740131 | 12774013 | 8 | Product used for unknown indication |
| 127740131 | 12774013 | 9 | Product used for unknown indication |
| 127740131 | 12774013 | 10 | Product used for unknown indication |
| 127740131 | 12774013 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127740131 | 12774013 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127740131 | 12774013 | Bradyphrenia | |
| 127740131 | 12774013 | Confusional state | |
| 127740131 | 12774013 | Dizziness | |
| 127740131 | 12774013 | Headache | |
| 127740131 | 12774013 | Hypokinesia | |
| 127740131 | 12774013 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |